BridgeMD
New treatment option for Uterine Fibroids (Leiomyoma)
Official title TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
ClinicalTrials.gov ID: NCT07480785
What this study is testing
What is triple antiemetic drugs?
triple antiemetic drugs is an investigational medicine, being studied as a potential treatment for uterine fibroids (leiomyoma).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate the effects of transcutaneous electrical acupoint stimulation (TEAS) combined with triple antiemetics for postoperative nausea and vomiting (PONV) in high-risk patients. The primary question it seeks to answer is: Does TEAS combined with triple antiemetics further reduce the incidence of PONV in high-risk subjects?
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Women scheduled for laparoscopic surgery ；
- Aged 18-65 years；
- ASA Class I-III；
- Apfel score ≥ 3 (female sex, non-smoker, history of PONV and/or motion sickness).
You likely can't join if
- Patients with a history of allergy to the investigational drug or contraindications；
- Long-QT syndrome ；
- Pregnancy, lactation, or menstruation ；
- Current smoker；
- Nausea/vomiting or use of antiemetics, opioids, or systemic corticosteroids within 24 h before surgery；
- Requirement for post-operative sedation and mechanical ventilation ；
See the full eligibility criteria
- Women scheduled for laparoscopic surgery ；
- Aged 18-65 years；
- ASA Class I-III；
- Apfel score ≥ 3 (female sex, non-smoker, history of PONV and/or motion sickness).
- Patients with a history of allergy to the investigational drug or contraindications；
- Long-QT syndrome ；
- Pregnancy, lactation, or menstruation ；
- Current smoker；
- Nausea/vomiting or use of antiemetics, opioids, or systemic corticosteroids within 24 h before surgery；
- Requirement for post-operative sedation and mechanical ventilation ；
- Severe renal or hepatic impairment ；
- Psychiatric or neurological disorder ；
- Vertebrobasilar insufficiency；
- Vestibular disease；
- Language or communication barrier ；
- Skin lesion or infection at the acupoint stimulation site ；
- Upper-limb nerve injury ；
- Implanted cardiac pacemaker or defibrillator ；
- Participation in another clinical trial within the past 4 weeks.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.